ADRC News

In October, Badger Talks will present three in-person events across Wisconsin focused on Alzheimer’s disease and other age-related topics. Each program features experts from the UW.

Ahead of the 2025 Fall Community Conversation, Kimberly Mueller, PhD, CCC-SLP, recently joined WISC-TV to discuss how untreated hearing loss may accelerate cognitive decline.

For University of Wisconsin–Madison students like Naureen Kamal and Mariam Siddiqui, conducting undergraduate research in the summer offers an important — and sometimes personal — avenue for discovery.

Nathaniel Chin, MD, medical director and Clinical Core co-leader of the Wisconsin Alzheimer’s Disease Research Center (ADRC), was one of three experts featured in a recent USA Today article for the health and wellness column.

Henrik Zetterberg, MD, PhD, and Hartmuth Kolb, PhD, have joined the UW School of Medicine and Public Health to study biomarkers in blood and spinal fluid that could help predict a person’s future risk of dementia.

More than 300 people attended the event, which took place on April 22, 2025, at the Discovery Building on the UW–Madison campus.

“It’s really because of the great Wisconsin participants that we now have something that’s pretty revolutionary,” Chin said to reporters.

In an advancement for Alzheimer’s disease diagnosis, the U.S. Food and Drug Administration (FDA) recently granted clearance for an Alzheimer’s disease blood test. Data samples used to evaluate the validity of the test are from research conducted at the University of Wisconsin–Madison.

Jeffrey Nirschl, MD, PhD, joined the "Open Record" podcast on May 7 — National Brain Donation Awareness Day — to honor brain donors and raise awareness about brain donations' vital role in advancing research on Alzheimer’s disease and related dementias.

Nathaniel Chin, MD, appeared on National Public Radio's (NPR) “All Things Considered” to discuss survey results published in the latest Alzheimer's Association annual report, which indicate that an increasing number of people are interested in testing for, diagnosing and treating Alzheimer's disease.